Canton Hathaway’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $277K | Buy |
1,492
+16
| +1% | +$2.97K | 0.06% | 125 |
|
|
2025
Q1 | $309K | Hold |
1,476
| – | – | 0.06% | 119 |
|
|
2024
Q4 | $262K | Hold |
1,476
| – | – | 0.07% | 91 |
|
|
2024
Q3 | $291K | Hold |
1,476
| – | – | 0.07% | 84 |
|
|
2024
Q2 | $253K | Hold |
1,476
| – | – | 0.07% | 85 |
|
|
2024
Q1 | $269K | Hold |
1,476
| – | – | 0.07% | 87 |
|
|
2023
Q4 | $229K | Hold |
1,476
| – | – | 0.07% | 87 |
|
|
2023
Q3 | $220K | Hold |
1,476
| – | – | 0.07% | 89 |
|
|
2023
Q2 | $199K | Sell |
1,476
-100
| -6% | -$13.5K | 0.06% | 95 |
|
|
2023
Q1 | $251K | Hold |
1,576
| – | – | 0.09% | 79 |
|
|
2022
Q4 | $255K | Hold |
1,576
| – | – | 0.09% | 78 |
|
|
2022
Q3 | $212K | Sell |
1,576
-31
| -2% | -$4.17K | 0.08% | 92 |
|
|
2022
Q2 | $246K | Sell |
1,607
-134
| -8% | -$20.5K | 0.09% | 93 |
|
|
2022
Q1 | $282K | Buy |
1,741
+1
| +0.1% | +$162 | 0.08% | 95 |
|
|
2021
Q4 | $236K | Hold |
1,740
| – | – | 0.06% | 106 |
|
|
2021
Q3 | $188K | Buy |
1,740
+1,001
| +135% | +$108K | 0.05% | 114 |
|
|
2021
Q2 | $83K | Buy |
739
+158
| +27% | +$17.7K | 0.02% | 136 |
|
|
2021
Q1 | $63K | Buy |
581
+431
| +287% | +$46.7K | 0.02% | 150 |
|
|
2020
Q4 | $16K | Buy |
+150
| New | +$16K | 0.01% | 204 |
|
|
2019
Q4 | – | Sell |
-130
| Closed | -$10K | – | 200 |
|
|
2019
Q3 | $10K | Hold |
130
| – | – | 0.01% | 183 |
|
|
2019
Q2 | $9K | Hold |
130
| – | – | 0.01% | 209 |
|
|
2019
Q1 | $10K | Buy |
+130
| New | +$10K | 0.01% | 210 |
|